Cell Death Clue: Ferroptosis Linked to Egg Cell Damage in Diminished Ovarian Reserve

Scientists studying why some women’s ovaries seem to age faster than the rest of their bodies have uncovered a striking molecular signature inside the tiny structures that nurture developing eggs. In a new study published in the Journal of Ovarian Research, a team of Turkish researchers reports that women with diminished ovarian reserve, or DOR, show hallmarks of ferroptosis, an iron-driven form of cell death, in the cumulus cells that surround and feed the oocyte, together with measurable damage to the mitochondria of the eggs themselves. The findings, drawn from 81 women undergoing fertility treatment, offer one of the most detailed looks yet at the follicular microenvironment of this poorly understood condition and suggest that oxidative stress may be a central player in the decline of egg quality.

Diminished ovarian reserve describes a situation in which the ovary holds fewer remaining follicles than expected for a woman’s age, often accompanied by reduced levels of anti-Müllerian hormone, or AMH, in the blood and a disappointing yield of eggs during in vitro fertilization cycles. For the millions of women who face this diagnosis, treatment options remain limited largely because the underlying biology has stayed elusive. While chromosomes, genetics and blood flow to the ovary have all been implicated, researchers have increasingly turned their attention to the follicular microenvironment, the local soup of cells, fluids and signaling molecules in which each egg matures. It is here, the new study suggests, that a specific and potentially targetable form of cellular damage may be at work.

Ferroptosis is not ordinary cell death. Unlike apoptosis, the tidy, programmed dismantling of a cell, ferroptosis is a violent chemical cascade in which iron catalyzes the peroxidation of lipids in cell membranes, literally rusting them from within. The process is held in check by glutathione peroxidase 4, or GPX4, an enzyme that repairs oxidized lipids and is considered the central guardian against ferroptotic collapse. When GPX4 activity falters or oxidative pressure overwhelms it, membranes rupture and the cell dies in a way that floods surrounding tissue with inflammatory signals. Because the ovary is rich in iron and because developing follicles are metabolically demanding, ferroptosis has emerged as a compelling suspect in ovarian dysfunction, but its role in DOR had never been directly examined in human follicular cells until now.

The research team, led by Nadiye Koroglu of Acibadem Mehmet Ali Aydinlar University and Aylin Yaba of Yeditepe University Faculty of Medicine, recruited 81 women undergoing intracytoplasmic sperm injection, a form of IVF in which a single sperm is injected directly into an egg. Forty-six of the participants had diminished ovarian reserve while 35 had normal ovarian reserve, serving as controls. During egg retrieval, the researchers collected cumulus cells, the specialized support cells that cling to the oocyte and supply it with nutrients, metabolic intermediates and developmental signals. They also sampled follicular fluid, the liquid that bathes the growing egg inside its follicle. Because cumulus cells share a intimate metabolic dialogue with the oocyte, damage to these cells can translate directly into compromised egg quality, making them an ideal window into follicular health.

The molecular readouts were revealing. Using quantitative reverse transcription polymerase chain reaction, the team measured the expression of ferroptosis-associated genes and found that both GPX4 and EMP1 were significantly elevated in the cumulus cells of DOR patients compared with controls. At first glance, higher GPX4 might seem protective, but the authors interpret this upregulation as a compensatory response: the cells appear to be mounting a defense against rising lipid peroxidation pressure, a molecular cry for help that indicates the ferroptosis machinery has been activated. Consistent with this interpretation, measurements of reactive oxygen species, or ROS, in the follicular fluid showed significantly higher concentrations in the DOR group, confirming an oxidatively stressed environment around the developing eggs. Notably, ferritin levels, a marker of iron storage, did not differ between the groups, suggesting that the oxidative damage in DOR is not simply a story of iron overload but of a broader redox imbalance.

The oocytes themselves told a parallel story of energetic decline. Using MitoTracker fluorescence, a dye that accumulates in active mitochondria in proportion to the electrical charge across their membranes, the researchers assessed germinal vesicle-stage oocytes, the immature eggs whose nuclear material is still enclosed. In eggs from women with DOR, mitochondrial membrane potential-related fluorescence was significantly reduced. This matters because the mitochondrial membrane potential is the engine of cellular energy production; a weakened potential means less ATP generation, poorer calcium handling and impaired completion of meiosis, all of which compromise the egg’s ability to be fertilized and develop into a viable embryo. Mitochondrial dysfunction has long been associated with reproductive aging, and this study provides direct evidence that it accompanies diminished ovarian reserve in human eggs retrieved during treatment.

Intriguingly, the study also probed the Hippo signaling pathway, an ancient growth-control network whose components, including MST1, LATS2 and YAP1, regulate organ size, cell proliferation and follicle activation. At the level of gene transcription, the Hippo pathway appeared unchanged: messenger RNA levels of MST1, LATS2 and YAP1 in cumulus cells did not differ between the DOR and control groups, whether measured directly or after the researchers manipulated ferroptosis in laboratory culture. But when the team turned to immunofluorescence staining to visualize the proteins themselves, a different picture emerged. Cumulus cells from DOR patients showed a significantly increased nuclear ratio of phosphorylated YAP to total YAP, along with elevated phosphorylated LATS1/2, while phosphorylated MST1 trended downward. These post-translational modifications indicate that DOR may modulate Hippo and YAP signaling not by changing how much of the pathway is produced, but by chemically altering the proteins after they are made, shifting their location and activity within the cell.

The technical achievement of the study lies in this multi-layered approach. By combining gene expression analysis, protein localization through immunofluorescence with DAPI-stained nuclei, biochemical assays of ROS and ferritin in follicular fluid, and live-cell fluorescence imaging of oocyte mitochondria, the researchers built a converging line of evidence from independent angles. Each measurement on its own could be dismissed as noise, but together they sketch a coherent mechanism: oxidative stress rises in the follicular fluid of DOR patients, cumulus cells respond by upregulating ferroptosis-defense genes, the Hippo pathway is re-tuned at the protein level, and the oocytes they support suffer measurable mitochondrial weakening. The slight, non-significant rise in intracellular ROS within cumulus cells themselves hints that the cells are under strain but have not yet crossed the threshold of overt damage, a snapshot of a process caught in progress.

The clinical implications are tantalizing, though the authors are careful to frame their findings as a foundation for further work rather than a treatment blueprint. If ferroptosis-associated oxidative stress genuinely contributes to the decline of egg quality in DOR, then interventions that shore up antioxidant defenses, such as GPX4-supporting compounds, iron chelators or lipid peroxidation inhibitors, could in principle protect the follicular microenvironment. The post-translational changes in Hippo signaling add a second potential lever, since YAP activity is known to influence follicle growth and activation, and pharmacological modulation of this pathway is an active area of reproductive research. Before any of that becomes reality, however, the findings will need to be replicated in larger and more diverse cohorts, and the causal direction will need to be established: whether ferroptotic stress drives diminished ovarian reserve or is merely a consequence of it remains the pivotal open question.

What the study undeniably delivers is a molecular portrait of a condition that has long been defined only by numbers, fewer follicles, lower AMH, fewer eggs retrieved. Behind those numbers, the research reveals a follicular ecosystem under oxidative siege, its support cells activating ancient cell-death defenses and its eggs running low on mitochondrial power. Part of this work was presented at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology in Paris in 2025, and the full study, funded by the Health Institutes of Turkey, is now open access, allowing clinicians and researchers worldwide to scrutinize the data. For women facing a DOR diagnosis, the research does not yet offer a therapy, but it does offer something arguably just as valuable: a specific, testable biological mechanism, and with it, a genuine target for the next generation of fertility research.

Subject of Research: Ferroptosis-associated oxidative stress and mitochondrial alterations in the follicles of women with diminished ovarian reserve

Article Title: Ferroptosis-associated oxidative stress in cumulus cells and mitochondrial alterations in oocytes of women with diminished ovarian reserve

Article References: Koroglu, N., Dogan, S., Aydin, T., Bican, G., Kilic, E., & Yaba, A. (2026). Ferroptosis-associated oxidative stress in cumulus cells and mitochondrial alterations in oocytes of women with diminished ovarian reserve. Journal of Ovarian Research. https://doi.org/10.1186/s13048-026-02265-w

Image Credits: AI Generated

DOI: 10.1186/s13048-026-02265-w

Keywords: ferroptosis, diminished ovarian reserve, cumulus cells, oxidative stress, oocyte, mitochondria, Hippo signalling pathway, GPX4, YAP, reactive oxygen species, fertility, IVF